Hopstem
develops and commercializes CNS drugs and biomarkers for the treatment of neurological diseases... Read moreHopstem
develops and commercializes CNS drugs and biomarkers for the treatment of neurological diseases... Read more
News
Nov 08, 2021
ChinaBio Today
Hopstem : Hopstem Bio Completes $40 Million B Round for Neural Stem Cell Therapy
Nov 01, 2021
Markets Insider
Hopstem : HOPSTEM completed 40 million USD series B financing, to develop safe, effective and affordable iPSC cell therapies for global patients
Jun 02, 2021
ChinaBio Today
Hopstem : Neurophth and Hopstem Partner to Develop Stem Cell Therapies for Eye Diseases
Dec 25, 2018
vcbeat
Hopstem : [Starting] has the world's leading iPS neural stem cell technology platform, Huo Wei Biological completed tens of millions of A round of financing